Pipeline

JPM has over 30 strategic products in its development pipeline. For more details on the potential for cooperation or co-development, please contact the licensing directorate.

The products that are currently under registration in Jordan are:

  • Andesart plus tablets
  • lowrac 10 tablets
  • insugen
  • lazedine tablets
  • Sincast 10 Tablets
  • Dimovasc 160/10 Tablets
  • Dimovasc 160/5 Tablets
  • Dimovasc 80/5 Tablets
  • Rosakit 20 Tablets
  • Rosakit 10 Tablets
  • Rosakit 5 Tablets
  • Talin 5XR Tablets
  • Gabanet 100 Tablets
Generic Drug
JPM Brand
© 2017 Jordanian Pharmaceutical Manufacturing Co. PLC. All Rights Reserved Powered By: ESKADENIA Software